← Leaderboards
John D Barks
University Of Michigan At Ann Arbor
$4,313,114
Attributed
$5,793,266
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $695.7K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,793,266 · 10
By mechanism
R01$2,497,729 · 2
R21$1,704,387 · 4
R61$762,891 · 1
R33$387,408 · 1
R29$364,914 · 1
R03$75,937 · 1
Top collaborators
- Stephen V Gliske3 shared
- Ronald D Chervin2 shared
- Renee A. Shellhaas2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- David M Aronoff$10,002,603
- Renee A. Shellhaas$5,989,043
- Chia-Ying Lin$3,242,520
- Ronald D Chervin$24,941,680
Others in their field
Top investigators on “Neonatal”
- George R Seage · Abt Associates, Inc.$223,371,661
- Abhik Das · Research Triangle Institute$189,877,011
- Carol Nesel · Westat$116,355,411
- Elizabeth A Thom · George Washington University$95,944,397
- Richard A Gibbs · Baylor College Of Medicine$82,807,896
- Sharon A Nachman · Johns Hopkins University$36,223,038
Research focus
NeonatalInfantNeonateHypoxiaExposure ToRodentInjuryDisabilityDoseResearch PersonnelLigationOxygenRattusFundingEvaluationProtocols DocumentationCaringNewborn InfantTranslatingBrainCarotid ArteriesLesionNatural HypothermiaBrain Injuries
Grant awards (22)
Sleep-disordered breathing in infants with myelomeningocele$695,712
R01 · FY2024 · HL · contact PI
Sleep-disordered breathing in infants with myelomeningocele$661,792
R01 · FY2023 · HL · contact PI
Real-time state of vigilance monitor for the neonatal intensive care unit$387,408
R33 · FY2022 · HL · contact PI
Drug Repurposing to Accelerate Progress in Neonatal Neuroprotection$195,000
R21 · FY2022 · HD · contact PI
Real-time state of vigilance monitor for the neonatal intensive care unit$382,540
R61 · FY2021 · HL · contact PI
Drug Repurposing to Accelerate Progress in Neonatal Neuroprotection$234,000
R21 · FY2021 · HD · contact PI
Real-time state of vigilance monitor for the neonatal intensive care unit$380,351
R61 · FY2020 · HL · contact PI
Repurposing Azithromycin for Neonatal Neuroprotection$234,000
R21 · FY2019 · HD · contact PI
Repurposing Azithromycin for Neonatal Neuroprotection$195,000
R21 · FY2018 · HD · contact PI
Maternal Diet and Susceptibility to Neonatal Brain Injury$226,719
R21 · FY2014 · HD · contact PI
Maternal Diet and Susceptibility to Neonatal Brain Injury$194,375
R21 · FY2013 · HD · contact PI
Docosahexaenoic Acid (DHA) and Neonatal Neuroprotection.$230,918
R21 · FY2012 · AT · contact PI
Docosahexaenoic Acid (DHA) and Neonatal Neuroprotection.$194,375
R21 · FY2011 · AT · contact PI
Enhancing Recovery after Neonatal Stroke$288,247
R01 · FY2008 · NS · contact PI
Enhancing Recovery after Neonatal Stroke$288,247
R01 · FY2007 · NS · contact PI
Enhancing Recovery after Neonatal Stroke$296,856
R01 · FY2006 · NS · contact PI
Enhancing Recovery after Neonatal Stroke$266,875
R01 · FY2005 · NS
PAF IN PERINATAL CEREBRAL HYPOXIC/ISCHEMIC INJURY$114,375
R29 · FY2002 · NS
PAF IN PERINATAL CEREBRAL HYPOXIC/ISCHEMIC INJURY$110,563
R29 · FY2001 · NS
PAF IN PERINATAL CEREBRAL HYPOXIC/ISCHEMIC INJURY$106,750
R29 · FY2000 · NS
MURINE DEVELOPMENTAL BRAIN INJURY$75,937
R03 · FY2000 · HD
PAF IN PERINATAL CEREBRAL HYPOXIC/ISCHEMIC INJURY$33,226
R29 · FY2000 · NS